Ware Grove
Analyst · First Analysis. Please go ahead
Thanks Steve, and good morning, everyone. As I normally do, I want to run through the highlights of the numbers we released this morning, for the fourth quarter and the year ended December 31, 2015. As a reminder, the numbers for 2014 include the results of the Miami office that was sold in the fourth quarter of 2014. With $5.4 million in revenue related to the Miami office during 2014, the year-over-year revenue comparisons reported for 2015 are adjusted to eliminate this from the 2014 numbers. In addition, there are share equivalence related to the accounting for the convertible note that are included in the fully diluted share count for both 2014 and for 2015. As you know, the convertible notes matured on October 1, 2015 and these notes are no longer outstanding. So as we have done in the past adjustments can be made to eliminate the impact of share equivalents on reported earnings per share. And I will comment on these adjustments as we go through the results announced earlier this morning. Thanks to the many CBIZ associates who are working hard to serve our clients across the United States. We are very pleased to report a year of revenue growth and expanding margins. Total revenue increased by 5% in the fourth quarter, and increased by 5.1% for the full year 2015 compared with the prior year. In margin on pretax income for the full year 2015 increased by 70 basis points. Within our Financial Services Group, same-unit organic revenue growth increased by 6.2% in the fourth quarter and increased by 3.4% for the full year. Within this group, the government healthcare consulting business continue to grow at high single-digit rates. This represents a highly recurring source of revenue and growth for us. We continue to successfully serve a number of states by providing Medicaid related consulting and audit services, and we are further expanding our services into the National Medicare space. We’ve made a number of lateral mid-level hires within the Financial Services Group, as an investment in future growth and I think we’ve talked about this in the past. But this is having an impact on margin within this group. Within the Employee Services group, same-unit organic revenue growth was relatively flat at 0.7% for the full year of 2015. As we have commented in prior calls, we’re not putting resources towards growing our life insurance services. This is a relatively small $4.1 million portion of our revenue within Employee Services group. So the impact is not significant, but we have seen a steady decline in that area. None of the impact to the life insurance area, organic revenue within our Employee Services group grew by 1.5% for the year. Our property and casualty services continue to grow organically. And we achieved nice growth within our payroll services as we continue to grow our client base and implement fee increases. We also achieved nice growth in the human capital management consulting businesses which include recruiting and compensation consulting services. The employee benefit service related organic revenue was relatively flat during 2015 and this was impacted by the loss of several larger clients earlier in 2015. Now on a good note, these headwinds were offset by record high new sales numbers achieved by our producer group for 2015. So I think we’re positioned well in that group. Throughout the Employee Services group, we also made a number of investments in new producers and client service personnel during the year, and these investments as they did with a Financial Services Group have impacted margins. Now, while we are investing to enhance resources to support our business groups. We continue to leverage our corporate G&A expense. We have provided the details in our footnote comments to the financial statements released this morning. But when you adjust to eliminate the impact of accounting for gains and losses on the deferred compensation plan assets. Our corporate G&A was 4.4% of revenue for 2015, compared with 4.7% of revenue for the prior year. And of course, you can clearly see a reduction in interest expense and the favorable impact on 2015 results. So the bottom line is that margin on pretax income was 7.7% of revenue in 2015, compared to a 7.0% a year earlier the increase of 70 basis points. This was in line with our expectations for 2015 and we are very pleased to record this level of margin increase on a 5.1% revenue growth for 2015. As a reminder, we continue to target a longer term goal of achieving 25 to 50 basis points of margin improvement annually over a longer period of time. The effective tax rate for the full year in 2015 was approximately 39.5%, this was slightly lower than the effective tax rate a year ago, which was approximately 39.9%. For planning purposes, we typically use an effective tax rate of 40% and we are using an effective tax rate of 40%, as we look ahead to 2016. At year-end 2015, there were approximately 1.2 million share equivalents, related to the convertible notes. And at year-end 2014 there were approximately 2.0 million share equivalents included in our reported share count. Including these share equivalents in the fully diluted share count is required for equity accounting. Since these shares are never issued and the notes have reached maturity and are no longer outstanding, we can’t eliminate the impact of these share equivalents, related to the notes. And therefore, use a normalized share count of approximately 51.5 million shares for 2015. This translates into a normalized earnings per share of $0.68 for 2015 and that compares with a normalized $0.61 per share for 2014 using an adjusted share count of 49.5 million shares for 2014. Now as a reminder, due to the very unpredictable nature of the share counts that we foresaw during 2015, our guidance early in the year and throughout the year that projected 12% to 15% increase in earnings per share for the full year of 2015, has always been based on a constant share count, using the adjusted base of 49.5 million shares for 2014. Using this constant share count this results in an EPS of $0.71, which is an increase of 16.4% over the normalized $0.61 reported for 2014. Now at approximately $50 million for the full year of 2015, cash flow generated by operating activities continues to be very strong. At year-end 2015, the balance outstanding on the $400 million unsecured credit facility was $205.8 million. And by design the credit facility easily accommodated the convertible note refinancing activity that occurred throughout 2015. At this point, we have plenty of financing capacity remaining to continue to fund an active acquisition program and provide flexibility to conduct share repurchases, as opportunities occur going into 2016. Days sales outstanding on receivables was 72 days at year-end 2015 and this compares with 70 days for the prior year-end. Bad debt expense for the full year of 2015 was 75 basis points against revenue and in 2014, bad debt expense was 76 basis points against revenue in that year. Capital spending for the full year 2015 was approximately $7.5 million. This was slightly higher than our normal range of $46 million of capital spending a year, due to a fairly significant move that occurred in the second quarter involving 100,000 square feet of office space, and approximately 450 associates in our Kansas City market. As we look ahead to 2016, we would expect capital spending to be within our normal range of $4 million to $6 million. On the acquisition front, we closed two transactions in the fourth quarter, and we announced a third transaction at the beginning of this year. During the full year 2015, we announced three acquisitions including the two I just mentioned in the fourth quarter and we used $26.6 million for acquisition related payments, including earn out payments for acquisitions made in prior years. As we look ahead, future earn out payment obligations are scheduled at $12.7 million this year in 2016, $7.9 million in 2017, and $2.9 million scheduled for 2018. Now during 2015, we repurchased approximately 3.8 million shares at a cost of approximately $35.2 million. Under 10b5-1 program, we have purchased an additional 632,000 shares to-date in 2016 at a cost of $6.1 million. Our Board recently approved the renewal of our annual authorization to repurchase up to five million shares. We will continue to opportunistically repurchase shares throughout 2016, with a view towards maintaining a relatively constant share count over time. However our first priority in the use of capital continues to be focused on strategic acquisitions. Going into 2016, we currently have plenty of financing capacity, but because our use of funds to repurchase shares is opportunistic and depends on multiple factors. It is not clear what volume of shares we may repurchase over the remainder of 2016. As I commented earlier, the convertible notes matured on October 1, 2015. Remember that in the second quarter of 2015, we retired $49.3 million of the notes, in a privately negotiated early retirement transaction where we issued 5.1 million shares plus cash. And in the fourth quarter, we settled the remaining $48.4 million balance outstanding on these notes, with a final payment of $71.8 million in cash. So as we look ahead to 2016, bear in mind the fully diluted share count will be impacted by these items. Considering that combined impact of both the newly issued shares in 2015, offset by the repurchase activity that occurred during 2015, and the repurchase activity to-date in 2016, we expect the fully diluted share count in 2016 to be approximately 53.3 million shares or about 3.5% higher than compared with a normalized share count of 51.5 million shares in 2015. As a result, as we look at 2016, the guidance, the expected increase in share count has a small impact on our guidance for earnings per share. So as we conclude looking at 2016, we expect revenue to increase within a range of 6% to 8% over 2015. Through continued leverage of expenses and expected lower interest expenses, we expect to improve pretax margin in 2016 within the range of our longer term goal of 25 to 50 basis points a year. Considering the impact of increased share count, we expect fully diluted earnings per share will increase within a range of 9% to 12% over the normalized $0.68 that we reported for 2015. Cash flow from operating activities will continue to be strong and EBITDA is expected to grow to within a range of $93 million to $95 million compared with the $87 million that we reported for 2015. So with these comments, I’ll conclude, and I’ll turn it back over to Steve.